Both in Biotechnology
Metagenomi Therapeutics vs Pelthos Therapeutics
Over the past year MGX returned −67.7% and PTHS returned −74.9%; their daily moves had a correlation of 0.09.
MGX −67.7% PTHS −74.9%Growth of $1, one year, split-adjusted
| Metric | MGX | PTHS |
|---|---|---|
| Price | $0.7308 | $9.30 |
| Market cap | $27.6M | $36.6M |
| Today | −7.49% | −8.37% |
| 1 month | −25.8% | −55.7% |
| 6 months | −48.5% | −62.8% |
| Year to date | −54.9% | −70.0% |
| 1 year | −68.1% | — |
| Revenue growth (YoY) | −103.0% | — |
| Gross margin | — | 76.9% |
| Net margin | — | −150.1% |
| P/E (TTM) | — | — |
| Price / sales | 2.0× | 0.8× |
| Net cash | $120.7M | -$45.7M |
| Dividend yield | — | — |
| Volatility (60d) | 49.8% | 141.3% |
| Short % of float | 5.2% | 8.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).